이은영 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

최종업데이트 2025.07.03.

Type 1 interferon signature and allograft inflammatory factor-1 contribute to refractoriness to TNF inhibition in ankylosing spondylitis
- Nat. Commun., Published: 01 July 2025 | https://doi.org/10.1038/s41467-025-60445-6
- 2025-07
- 의약학
- 한빛사논문
Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathy
- Ann. Rheum. Dis., Jan 31 2025, S0003-4967(25)00070-6 | https://doi.org/10.1016/j.ard.2024.11.005
- 2025-01
- 생명과학
- 한빛사논문
Single cell transcriptome and surface protein expression analysis identify OX40+ GITR+ pathogenic T helper 17 in ankylosing spondylitis
- Arthritis Rheumatol., First published: 14 February 2023 | https://doi.org/10.1002/art.42476
- 2023-02
- 의약학
- 한빛사논문
RANKL-responsive epigenetic mechanism reprograms macrophages into bone-resorbing osteoclasts
- Cell. Mol. Immunol., 2023 Jan;20(1):94-109 | doi: 10.1038/s41423-022-00959-x
- 2023-01
- 생명과학
- 한빛사논문
Germline gain-of-function mutation of STAT1 rescued by somatic mosaicism in immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like disorder
- J. Allergy Clin. Immunol., Available online 2 December 2019 | https://doi.org/10.1016/j.jaci.2019.11.028
- 2019-12
- 의약학
- 한빛사논문
CXCL10 and autoimmune diseases
- Autoimmunity Reviews, Volume 8, Issue 5, March 2009, Pages 379-383 | https://doi.org/10.1016/j.autrev.2008.12.002
- 2009-03
- 의약학
- 상위피인용논문

연구자 ID

저자논문